Insights Center
ML Strategies Viewpoints
Search
Showing 65 - 72 of 492 results
ML Strategies Weekly Health Care Preview - June 25, 2018
June 25, 2018|Blog
House Approves Sweeping Health Care Legislation
June 25, 2018|Alert
Opioids Have Our Attention
June 21, 2018|Blog
Further Efforts to Repeal and Replace
June 20, 2018|Blog
ML Strategies Health Care Preview - June 18th
June 18, 2018|Blog
ML Strategies Health Care Preview - June 11th
June 11, 2018|Blog
ML Strategies Health Care Preview - June 4, 2018
June 4, 2018|Blog
News & Press Releases
To Pitch Pre-Cert to Congress, FDA Builds a Case First
September 26, 2019 | MedTechDive
MedTechDive reported that the U.S. Food and Drug Administration is not yet ready to go to Congress to seek new powers for its evolving precertification pilot for software, but it will need new authorities to determine how the experimental path fits into the current regulatory scheme. The article included commentary from Senior Director of ML Strategies Aaron Josephson and Mintz Associate Benjamin Zegarelli.
Former FDAer Defends FDA Decision to Withdraw Data Falsification Rule
August 20, 2019 | Inside Health Policy
An article published by Inside Health Policy quoted Aaron Josephson, Senior Director at ML Strategies, extensively in response to recent debate surrounding the U.S. Food and Drug Administration’s proposed rule “Reporting Information Regarding Falsification of Data,” which was previously withdrawn.
Events
Nov
8
2019